Navigation Links
Digirad Signs Exclusive International Distribution Agreement with Dilon Diagnostics
Date:8/22/2013

SUWANEE, Ga. and NEWPORT NEWS, Va., Aug. 22, 2013 /PRNewswire/ -- Digirad Corporation (NASDAQ: DRAD),  the leader in solid-state diagnostic imaging technology and services, and Dilon Diagnostics, the world leader in molecular breast imaging, today announced that they have signed an exclusive international distribution agreement for Dilon to distribute Digirad's lines of nuclear imaging cameras including the ergo™, a large field-of-view general purpose imaging system, the Cardius® x.act, a triple-head cardiac dedicated SPECT imaging system with VCT Attenuation Correction, and the Cardius® XPO dedicated cardiac SPECT imaging systems line.  The agreement covers distribution of Digirad products to most countries outside the United States.  The signing of this agreement furthers the relationship that Digirad and Dilon have been building since the two companies signed a technology development agreement in mid-2010.

(Logo:  http://photos.prnewswire.com/prnh/20130501/PH05456LOGO )

Digirad President and CEO Matthew G. Molchan said, "We are very pleased with this enhanced relationship with Dilon and the opportunity to further expand our product reach beyond the United States.  We continue to believe that our nuclear imaging cameras, with their solid-state design and technology, are well suited to meet the needs of the international market and we are very excited to partner with Dilon to distribute our cameras around the world.  We believe our products will be an excellent complement to the already extensive Dilon product line up."   

Dilon Diagnostics Chairman and CEO Robert G. Moussa said, "We are extremely pleased to expand our alre
'/>"/>

SOURCE Dilon Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
2. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
3. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
4. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
5. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
6. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
7. Bacterin International Signs Its Third National GPO Contract with Novation
8. MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete
9. Masimo Signs Pronto-7™ Distribution Deal with Henry Schein
10. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
11. Wellness Center USA Inc. Signs Agreement to Acquire Psoria-Shield Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)...  Boston Scientific Corporation (NYSE: BSX ) ... quarter ended March 31, 2015, compared to the ... to $1.800 billion.  This represents 6 percent operational ... and flat revenue on a reported basis, all ... achieved adjusted earnings per share of $0.21 for ...
(Date:4/28/2015)... PARSIPPANY, N.J. and INDIANAPOLIS , ... who undergo an angioplasty procedure and receive a heart stent ... help prevent a heart attack, a blood clot in their ... survey conducted by Harris Poll found that 52 percent of ... missed taking or changed the way they take their prescribed ...
(Date:4/28/2015)... April 28, 2015  Shares of Celladon Corp. (NASDAQ: ... yesterday following the announcement of poor drug trial results of ... gene therapy agent, MYDICAR.  The selloff may be warranted ... company at bargain basement prices. An analyst ... overview, current pipeline, financial review, analyst summary, valuation, and ...
Breaking Medicine Technology:Boston Scientific Announces Results for First Quarter 2015 2Boston Scientific Announces Results for First Quarter 2015 3Boston Scientific Announces Results for First Quarter 2015 4Boston Scientific Announces Results for First Quarter 2015 5Boston Scientific Announces Results for First Quarter 2015 6Boston Scientific Announces Results for First Quarter 2015 7Boston Scientific Announces Results for First Quarter 2015 8Boston Scientific Announces Results for First Quarter 2015 9Boston Scientific Announces Results for First Quarter 2015 10Boston Scientific Announces Results for First Quarter 2015 11Boston Scientific Announces Results for First Quarter 2015 12Boston Scientific Announces Results for First Quarter 2015 13Boston Scientific Announces Results for First Quarter 2015 14Boston Scientific Announces Results for First Quarter 2015 15Boston Scientific Announces Results for First Quarter 2015 16Boston Scientific Announces Results for First Quarter 2015 17Boston Scientific Announces Results for First Quarter 2015 18Boston Scientific Announces Results for First Quarter 2015 19Boston Scientific Announces Results for First Quarter 2015 20Boston Scientific Announces Results for First Quarter 2015 21Boston Scientific Announces Results for First Quarter 2015 22Boston Scientific Announces Results for First Quarter 2015 23Boston Scientific Announces Results for First Quarter 2015 24Boston Scientific Announces Results for First Quarter 2015 25Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 2Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 3Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 4Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 5Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 6Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 7Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 8Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 9Examining what's Left after MYDICAR Drug Trial Ends In Failure; Celladon Corp. Analyst Report Issued by BrokerBank Securities, Inc. 2
... Knopp Neurosciences Inc. ("Knopp"),announced that the U.S. ... Development has granted orphan drug designation to ... (ALS). (Logo: http://www.newscom.com/cgi-bin/prnh/20070924/KNOPPLOGO ) ... studies to evaluate the safety,tolerability and pharmacokinetics ...
... on stringent endpoint of clinical ... PHILADELPHIA, Oct. 15 An analysis of data to,be ... Scientific Meeting found that Asacol, dosed at 2.4 g/day, ... active,ulcerative colitis (UC). The analysis was based on data ...
Cached Medicine Technology:Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS 2New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 2New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 3New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 4
(Date:4/28/2015)... Vancouver, BC (PRWEB) April 28, 2015 ... published a blog stating that it is smarter to ... of a personal injury claim. The blog reasons that ... lawyer since these professional are well-versed with the law ... the client would be able to on their own. ...
(Date:4/28/2015)... City, Missouri (PRWEB) April 28, 2015 ... by the American Museum of Natural History, will open ... spring 2016, supported by sponsorship from Saint Luke’s Health ... New York City, Toronto, Granada and Milan, this one-of-a-kind ... about science and technology. , “Saint Luke’s and ...
(Date:4/28/2015)... Chicago, IL (PRWEB) April 28, 2015 ... enhance its research and healthcare services programs, the ... Orlando, Ph.D. Orlando comes to MDA from Fidelity ... oversaw funding of research projects in neurodegenerative diseases ... scientific conferences. Prior to her time at Fidelity, ...
(Date:4/28/2015)... Colorado (PRWEB) April 28, 2015 Colorado ... an updated version of his popular spine education website ... ASKSPINEDOC.COM developed by eMedical Media. This website has ... of the anatomy of the spine, causes of neck ... Dr. Corenman created this website and personally answers questions ...
(Date:4/28/2015)... OsteoRemedies®, LLC, Memphis, TN, offers the ... infected hip and knee arthroplasty. , ... pre-loaded spacer with Gentamicin Antibiotics, for consistent and ... Combined with a consistent process for polishing the ... for temporary use for up to 180 days. ...
Breaking Medicine News(10 mins):Health News:Vancouver Personal Injury Lawyers Recently Stated in Latest Blog That It Is Smarter To Call A Lawyer Before ICBC 2Health News:Saint Luke's Health System to sponsor Brain: The Inside Story exhibition at Museum at Prairiefire 2Health News:MDA Adds Neurological Disease Expert to Research Team 2Health News:MDA Adds Neurological Disease Expert to Research Team 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3
... debilitating headaches , , THURSDAY, Feb. 12 (HealthDay News) -- Being ... and middle-aged adults, suggests a U.S. study that included 22,211 ... was distributed affected migraine risk. People ages 20 to 55 ... than those with smaller waistlines. , Migraine was reported by ...
... By The Bay, a regional resource for hospice ... end-of-life care at no charge to all healthcare ... starting in March. CEUs are available. The ongoing ... held in Larkspur. For the schedule of trainings, ...
... MINNEAPOLIS, Feb. 12 Biotel Inc.,(OTC Bulletin Board: BTEL) ... with net earnings of $289,000, or $0.10 per diluted ... of $206,000, or $0.07,per diluted share, on revenues of ... six months ended December 31, 2008, Biotel had net ...
... The Disabled American Veterans today applauds the introduction ... predictable funding for veterans health care and an ... budget process."The Veterans Health Care Budget Reform and ... efficient, transparent and accountable. These are three key ...
... the government,s vaccine program," says SafeMinds.WASHINGTON, Feb. 12 ... three families who argued that vaccination contributed to their ... on inadequate vaccine safety science available to the court. ... the defendant in "vaccine court" and is also responsible ...
... Arrow Group, a New York-based full-service strategic consulting ... Schweinitz has joined the company.As a member of ... be responsible for driving business growth by ensuring ... expanding Big Arrow,s offerings and expertise, especially in ...
Cached Medicine News:Health News:Belly Fat May Make Migraines More Likely 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 3Health News:Biotel Announces Profitable Second Quarter Ended December 31, 2008 2Health News:Veterans Health Care Funding Reform Bill Promises Transparency, Accountability 2Health News:Veterans Health Care Funding Reform Bill Promises Transparency, Accountability 3Health News:Federal Vaccine Court Rulings Against Autism Families Due to Government's Refusal to Fund Sound Science 2Health News:Big Arrow Group Expands Global Capabilities with Addition of Anne de Schweinitz 2
... Insta Test is an immunochromatography ... It is designed for qualitative ... specimens. The presence of myoglobin ... or higher can be detected ...
This advanced digital monitor detects the appearance of an irregular heartbeat during measurement and gives a warning signal with your reading. An irregular heartbeat may cause or indicate cardiovasc...
... (PSA) is a serine protease that is found ... of the acini and ducts. Normal PSA concentration ... Reports have suggested that elevated level of whole ... tumor markers in diagnosis of prostate cancers. InstaTest ...
... 25-Hydroxyvitamin D Assay is for use only ... Nichols Advantage® 25-Hydroxyvitamin D Assay is intended ... (25-OH-D) and other hydroxylated metabolites of vitamin ... used as an aid in the assessment ...
Medicine Products: